Louisiana State Employees Retirement System Has $722,000 Position in ICU Medical Inc. (ICUI)
Louisiana State Employees Retirement System continued to hold its stake in ICU Medical Inc. (NASDAQ:ICUI) during the second quarter, Holdings Channel reports. The institutional investor owned 6,400 shares of the company’s stock at the end of the second quarter. Louisiana State Employees Retirement System’s holdings in ICU Medical were worth $722,000 as of its most recent filing with the SEC.
Several other hedge funds also recently added to or reduced their stakes in the stock. Bank of Montreal Can bought a new stake in ICU Medical during the second quarter worth about $133,000. M&T Bank Corp raised its stake in ICU Medical by 3.3% in the first quarter. M&T Bank Corp now owns 2,117 shares of the company’s stock worth $220,000 after buying an additional 67 shares during the last quarter. Bayesian Capital Management LP raised its stake in ICU Medical by 0.3% in the first quarter. Bayesian Capital Management LP now owns 2,150 shares of the company’s stock worth $224,000 after buying an additional 7 shares during the last quarter. Checchi Capital Advisers LLC bought a new stake in ICU Medical during the second quarter worth about $242,000. Finally, Eqis Capital Management Inc. raised its stake in ICU Medical by 0.7% in the second quarter. Eqis Capital Management Inc. now owns 2,509 shares of the company’s stock worth $283,000 after buying an additional 18 shares during the last quarter. Institutional investors own 89.52% of the company’s stock.
ICU Medical Inc. (NASDAQ:ICUI) traded down 0.81% during trading on Tuesday, reaching $148.75. The company had a trading volume of 205,106 shares. The firm’s 50-day moving average price is $126.86 and its 200 day moving average price is $113.00. ICU Medical Inc. has a one year low of $85.56 and a one year high of $152.67. The firm has a market capitalization of $2.40 billion, a P/E ratio of 44.30 and a beta of 0.37.
ICU Medical (NASDAQ:ICUI) last released its quarterly earnings results on Monday, August 8th. The company reported $1.15 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.05 by $0.10. The firm had revenue of $96.70 million for the quarter, compared to the consensus estimate of $89.66 million. ICU Medical had a return on equity of 10.33% and a net margin of 14.94%. The company’s revenue for the quarter was up 15.4% on a year-over-year basis. During the same period last year, the business posted $0.97 EPS. Equities analysts forecast that ICU Medical Inc. will post $4.54 earnings per share for the current fiscal year.
A number of research firms recently issued reports on ICUI. Zacks Investment Research upgraded ICU Medical from a “hold” rating to a “buy” rating and set a $140.00 price objective on the stock in a research note on Friday, August 12th. Piper Jaffray Cos. reiterated a “neutral” rating and set a $119.00 price objective (up from $115.00) on shares of ICU Medical in a research note on Thursday, August 11th.
In related news, Director Richard Md Sherman sold 1,500 shares of the firm’s stock in a transaction on Thursday, October 6th. The stock was sold at an average price of $140.60, for a total value of $210,900.00. Following the transaction, the director now directly owns 70,699 shares of the company’s stock, valued at approximately $9,940,279.40. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Chairman Vivek Jain sold 7,268 shares of the firm’s stock in a transaction on Wednesday, August 24th. The stock was sold at an average price of $124.25, for a total value of $903,049.00. Following the completion of the transaction, the chairman now directly owns 48,497 shares in the company, valued at $6,025,752.25. The disclosure for this sale can be found here. 15.90% of the stock is owned by insiders.
About ICU Medical
ICU Medical, Inc is engaged in the development, manufacturing and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company’s product line includes needlefree connection devices, closed system transfer devices (CSTD), needlefree closed blood sampling systems, disposable pressure transducer systems and hemodynamic monitoring systems.
Want to see what other hedge funds are holding ICUI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ICU Medical Inc. (NASDAQ:ICUI).
Receive News & Ratings for ICU Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.